As a precautionary measure, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class one recall of Oxybutynin Hydrochloride.

The Oxybutynin Hydrochloride is used to treat urinary incontinence and other bladder conditions and is commonly prescribed to children with an uncontrollable nocturnal bladder or elderly people with bladder control problems.

MHRA is recalling four batches of 5mg tablets; according to the agency these batches might contain high levels of an active ingredient.

The affected batch numbers are 09D02, 09D04, 146401 and 146402.

The findings were made during the early stages of the drug’s production and to be on the safe side, the MHRA decided to recall these batches while an investigation takes place.